atropine has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Y; Li, W; Wang, JQ | 1 |
| Akino, H; Aoki, Y; Ito, H; Matsuta, Y; Miwa, Y; Nakai, M; Oyama, N; Tanase, K; Yokoyama, O; Yusup, A | 1 |
2 other study(ies) available for atropine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
microRNA-33A expression is reduced in cerebral cortex in a rat model of ischemic tolerance.
Topics: Animals; Atropine; Cerebral Cortex; Disease Models, Animal; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Ischemic Preconditioning; Male; MicroRNAs; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Severity of Illness Index | 2015 |
Effects of antimuscarinics on voiding function after cerebral infarction in a rat model of overactive bladder.
Topics: Animals; Atropine; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive; Urinary Catheterization; Urination | 2007 |